Osteocalcin: a potential marker of metastatic bone disease and response to treatment

Hauschka, 1975, Direct identification of the calcium-binding amino acid, γ-carboxyglutamate in mineralised tissue, 72, 3925 Price, 1976, Characterization of γ-carboxyglutamic acid-containing protein from bone, 73, 1447 Nishimoto, 1979, Proof that the γ-carboxyglutamic acid-containing bone protein is synthesised in calf bone, J Biol Chem, 254, 437, 10.1016/S0021-9258(17)37936-X Price, 1981, Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone, J Biol Chem, 256, 12760, 10.1016/S0021-9258(18)42960-2 Price, 1980, Radioimmunoassay for the vitamin K-dependent protein and its discovery in plasma, 77, 2234 Price, 1980, New biochemical marker for bone metabolism, 66, 878 Malluche, 1984, Plasma levels of GLA protein reflect bone formation in patients on chronic maintenance dialysis, Kidney Int, 26, 869, 10.1038/ki.1984.230 Brown, 1984, Serum bone GLA protein: A specific marker for bone formation in postmenopausal osteoporosis, Lancet, i, 1091, 10.1016/S0140-6736(84)92506-6 Delmas, 1986, Serum bone γ-carboxyglutamic acid-containing protein in primary hyperparathyroidism and in malignant hypercalcaemia, J Clin Invest, 7, 985, 10.1172/JCI112400 Slowik, 1984, Clinical evaluation of bone turnover by serum osteocalcin measurements in a hospital setting, J Clin Endocrinol Metab, 59, 228, 10.1210/jcem-59-2-228 Coleman, 1985, Breast cancer and bone metastases, Cancer Treat Rev, 12, 251, 10.1016/0305-7372(85)90008-8 Bataille, 1987, Serum bone gla-protein in multiple myeloma, Cancer, 59, 329, 10.1002/1097-0142(19870115)59:2<329::AID-CNCR2820590227>3.0.CO;2-S Coleman, 1986, Assessment of osteoblast activity predicts radiological response to treatment, 27, 180 Coleman RE, Rubens RD, Fogelman I. The bone scan flare following systemic therapy for bone metastases. J Nucl Med (in press). Moss, 1984, Improved electrophoretic resolution of bone and liver alkaline phosphatases resulting from partial digestion with neuraminidase, Clin Chim Acta, 143, 177, 10.1016/0009-8981(84)90227-4 Moss, 1975, A simplified heat-inactivation method for investigating alkaline phosphatase isoenzymes in serum, Clin Chim Acta, 61, 63, 10.1016/0009-8981(75)90398-8 Coleman, 1987, Treatment of hypercalcaemia secondary to advanced breast cancer with 3-(amino-1,1-hydroxypropylidene) bisphosphonate, Br J Cancer, 56, 465, 10.1038/bjc.1987.225 Hayward, 1977, Assessment of response to therapy in advanced breast cancer, Eur J Cancer, 13, 89, 10.1016/0014-2964(77)90234-1 Body, 1986, Serum osteocalcin (BGP) in tumour-associated hypercalcaemia, J Bone Min Res, 1, 523, 10.1002/jbmr.5650010606 Coleman, 1987, The clinical course of bone metastases, Br J Cancer, 55, 61, 10.1038/bjc.1987.13 Rossleigh, 1984, The assessment of response to therapy of bone metastases in breast cancer, Aust NZ J Med, 14, 19, 10.1111/j.1445-5994.1984.tb03578.x Valentin-Opran, 1982, Quantitative histology of myeloma-induced bone changes, Br J Haematol, 52, 601, 10.1111/j.1365-2141.1982.tb03936.x Deftos, 1982, Changes in plasma bone GLA protein during treatment of bone disease, Calcif Tiss Int, 34, 121, 10.1007/BF02411221 Coleman, 1987, Biochemical assessment predicts radiological response in bone metastases from breast cancer, Bone, 8, 266, 10.1016/8756-3282(87)90186-4